Upsher-Smith Hosts Iowa Governor for Roundtable Discussion & Facility Tour

Upsher-Smith Laboratories, a Midwest-based pharmaceutical company focused on specialty brands and generics, currently part of Bora Group, recently welcomed Iowa Governor Kim Reynolds to its Maple Grove, Minnesota headquarters for a roundtable discussion and facility tour focused on advancing pharmaceutical innovation and exploring opportunities for regional collaboration.

As part of his domestic mission trip, Governor Reynolds met with leaders from Upsher-Smith and Bora Group to discuss onshoring pharmaceutical manufacturing, strengthening supply chain integration across the Midwest, and expanding contract development and manufacturing.

The visit began with a tour of the Maple Grove manufacturing facility and a discussion about growing domestic manufacturing and Contract Development and Manufacturing Organization (CDMO) opportunities, both critical components of a resilient pharmaceutical supply chain.

Bora Group leaders shared insights into the company’s integrated global network, pharmaceutical development and manufacturing capabilities, and vision for expanding CDMO partnerships in the U.S.

“Bora is deeply committed to strengthening pharmaceutical manufacturing here in the U.S.,” said Dennis Hall, Vice President and General Manager, Bora Pharmaceuticals. “As a global CDMO with a growing domestic footprint, we see tremendous opportunity for investment, innovation, and collaboration. We appreciate leaders like Governor Reynolds who understand the critical role of a resilient, U.S.-based supply chain in ensuring patients have consistent access to essential medicines.”

To date, Bora has invested hundreds of millions of dollars in domestic infrastructure. In 2023, Upsher-Smith opened a new, 270,000 square-foot greenfield manufacturing facility in Maple Grove, MN.